Fulgent Genetics Inc expected to post a loss of 18 cents a share - Earnings Preview

Fulgent Genetics

30/04/2025 13:37

Fulgent Genetics Inc FLGT.OQ FLGT.O is expected to show a rise in quarterly revenue when it reports  results on May 2 for the period ending March 31 2025

The El Monte California-based  company is expected to report a 10.5% increase in revenue to $71.257 million from $64.49 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Fulgent Genetics Inc is for a loss of 18 cents per share.

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Fulgent Genetics Inc is $20.00​, above​ its last closing price of $18.13. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-0.12
-0.12
0.04
Beat
132.4
Sep. 30 2024
-0.15
-0.15
0.31
Beat
302.2
Jun. 30 2024
-0.30
-0.30
0.15
Beat
150​
Mar. 31 2024
-0.32
-0.32
-0.01
Beat
96.9
​​Dec. 31 2023
-0.28
-0.29
0.28
Beat
197.7
Sep. 30 2023
-0.35
-0.33
-0.39
Missed
-18.2​
Jun. 30 2023
-0.33
-0.33
-0.08
Beat
75.6
Mar. 31 2023
-0.43
-0.43
-0.22
Beat
48.4

This summary was machine generated April 30 at 12:36 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)